Search - tctmd.com

Displaying 761 - 780 of 892

Sort: Relevancy | Date

News Conference News ESC 2014

Post-Acute MI Survival Improving for Elderly Patients in France

Todd Neale

August 30, 2014

Presentation

Post-Procedural Anticoagulation for Specific Indications After Revascularization for STEMI

Presenter: M. V. Madhavan

August 27, 2014

News Daily News

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

Todd Neale

August 20, 2014

News Daily News

OCT Appears to Help Identify ACS Patients Who Can Forgo Stenting

August 07, 2014

News Daily News

Meta-analysis: Patient Sex Affects Response to Routine Invasive Approach for NSTE-ACS

Todd Neale

July 30, 2014

News Daily News

Long-term Mortality Worse for Black vs White NSTEMI Patients, Linked with Treatment Discrepancies

July 17, 2014

News Daily News

Subestudio ACUITY: La Puntuación obtenida en la Escala Syntax Guarda Relación con la Trombosis del Stent en Pacientes SCASEST

L.A. McKeown

July 09, 2014

News Daily News

ACUITY Substudy: Syntax Score Correlates with Stent Thrombosis in NSTE-ACS Patients

L.A. McKeown

July 09, 2014

News Daily News

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

July 08, 2014

News Daily News

Coronary Dominance Plays Role in Early Post-STEMI Mortality Risk

Yael L. Maxwell

June 24, 2014

News Daily News

Manual Thrombectomy Optimizes PCI, But No Long-term Benefit in STEMI

Yael L. Maxwell

June 03, 2014

News Conference News EuroPCR 2014

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

Yael L. Maxwell

May 21, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Daily News

Coronary Microvascular Dysfunction Common in Both Sexes, Predicts MACE

May 07, 2014

Presentation

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

Presenter: D. Lindholm

April 25, 2014

News Daily News

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

L.A. McKeown

April 25, 2014

News Daily News

HORIZONS-AMI Substudy Examines Effects of Obesity on STEMI Outcomes

Yael L. Maxwell

April 24, 2014

News Daily News

Patients with Cardiac Arrest Fare Poorly After PCI

April 17, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

Presentation PCI Outcomes 2014

Primary PCI in STEMI: The Controversy of Culprit Only vs Immediate vs Delayed Revascularization

Presenter: Stephan Windecker

March 28, 2014

Advertisement

Post-Acute MI Survival Improving for Elderly Patients in France

Post-Procedural Anticoagulation for Specific Indications After Revascularization for STEMI

Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI

OCT Appears to Help Identify ACS Patients Who Can Forgo Stenting

Meta-analysis: Patient Sex Affects Response to Routine Invasive Approach for NSTE-ACS

Long-term Mortality Worse for Black vs White NSTEMI Patients, Linked with Treatment Discrepancies

Subestudio ACUITY: La Puntuación obtenida en la Escala Syntax Guarda Relación con la Trombosis del Stent en Pacientes SCASEST

ACUITY Substudy: Syntax Score Correlates with Stent Thrombosis in NSTE-ACS Patients

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

Coronary Dominance Plays Role in Early Post-STEMI Mortality Risk

Manual Thrombectomy Optimizes PCI, But No Long-term Benefit in STEMI

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

Coronary Microvascular Dysfunction Common in Both Sexes, Predicts MACE

Ticagrelor vs Clopidogrel in Patients with NSTE-ACS With or Without Revascularization

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

HORIZONS-AMI Substudy Examines Effects of Obesity on STEMI Outcomes

Patients with Cardiac Arrest Fare Poorly After PCI

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Primary PCI in STEMI: The Controversy of Culprit Only vs Immediate vs Delayed Revascularization

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content